-
AstraZeneca Imfinzi approved by FDA for postoperative adjuvant therapy in non-small cell lung cancer patients
The US Food and Drug Administration (FDA) approved a new therapy for the best-selling anti-cancer drug Imfinzi from British pharmaceutical giant AstraZeneca on Thursday (August 15th). According to me ...